Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.40 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.36 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21184290 | 1.00 | FBP1 (0.40) | FBP1AMDHD2FUCA1 | |
| SCHEMBL15368857 | 1.00 | FBP1 (0.40) | FBP1AMDHD2FUCA1 | |
| SCHEMBL21184378 | 0.83 | FBP1 (0.33) | FBP1AMDHD2 | |
| SCHEMBL21184380 | 0.83 | FBP1 (0.33) | FBP1AMDHD2 | |
| SCHEMBL21701356 | 0.81 | FBP1 (0.42) | FBP1AMDHD2 | |
| SCHEMBL15491281 | 0.79 | FBP1 (0.41) | FBP1AMDHD2 | |
| SCHEMBL17918378 | 0.78 | FBP1 (0.40) | FBP1AMDHD2 | |
| SCHEMBL23314206 | 0.75 | — | — | |
| SCHEMBL14985153 | 0.74 | FBP1 (0.75) | FBP1AMDHD2 | |
| SCHEMBL23960812 | 0.74 | FBP1 (0.75) | FBP1AMDHD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190225644-A1 | MRNA CAP ANALOGS AND METHODS OF MRNA CAPPING | MODERNATX, INC. | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225644-A1 | MRNA CAP ANALOGS AND METHODS OF MRNA CAPPING | RNGTT, RNMT, NSUN2 | FBP1 2442/4885AMDHD2 959/4885FUCA1 3284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.